Share on LinkedInShare on LinkedIn

ARTICLE · 11 OCTOBER 2013

Ouch, Treble Damages In False Advertising Cases?

This blog reports frequently on the troubles Syringemarketers get into with the FTC, State AGs, the NAD, under the Lanham Act, or from class actions based on making allegedly false statements about their products or their competitors’ products.

United StatesMedia, Telecoms, IT, Entertainment

This blog reports frequently on the troubles marketers get into with the FTC, State AGs, the NAD, under the Lanham Act, or from class actions based on making allegedly false statements about their products or their competitors' products.  A recent $113 million jury verdict in Texas reminds us that the antitrust laws can come into play as well for such conduct, if an actor with monopoly or market power can be said to be unlawfully excluding its rivals by its advertising or marketing techniques. 

Retractable Technologies ("Retractable") developed a disposable retractable point or "safety" syringe designed to reduce the risk of accidental needle sticks for health care workers and to eliminate the possibility that syringes would be reused.  Among other things, these features would help reduce the risk that health care workers would be exposed to the HIV virus and that used syringes would be re-used for illegal drug use.  Becton Dickinson ("BD") possessed a dominant

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from